|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustment to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of right-of-use assets | |||||
| Stock-based compensation costs (note 10) | |||||
| Loss attributable to equity method investments (note 6) | |||||
| Restructuring expenses (note 18) | |||||
| (Gain) loss attributable to equity method investments, net of dividends received (note 6) | |||||
| (Gain) loss on equity investments (note 6) | |||||
| Gain on previously held equity investment (note 6) | |||||
| Restructuring expenses (note 17) | |||||
| Gain on insurance recoveries | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses, net deferred income taxes and other current assets | |||||
| Accounts payable, accrued expenses and other | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property, plant and equipment | |||||
| Patent registration costs | |||||
| Purchases of intangible assets | |||||
| Business acquisitions, net of cash acquired | |||||
| Purchases of investments (note 6) | |||||
| Proceeds from exits of investments (note 6) | |||||
| Proceeds (payments) on maturity of foreign currency contracts | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock, net | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Purchases of treasury stock | |||||
| Payments of business combination contingent consideration | |||||
| Acquisition of consolidated subsidiary | |||||
| Proceeds from borrowings, net of borrowing costs | |||||
| Repayment of borrowings | |||||
| Dividends paid | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Income taxes paid, net of refunds | |||||
| Interest paid | |||||
| Fair value of assets acquired, excluding cash | |||||
| Liabilities assumed | |||||
| Goodwill on acquisition | |||||
| Previously held equity investment | |||||
| Deferred payments | |||||
| Fair value of contingent consideration | |||||
| Cash paid for acquisitions | |||||
Loading...